Pirjo Nuutila
Professor, MD, PhD
Turku PET centre pirjo.nuutila@utu.fi +358 29 450 2569 +358 40 162 6834 Kiinamyllynkatu 4-8 Turku ORCID identifier: https://orcid.org/0000-0001-9597-338X(external) |
Publications 
3 of 24
- Evaluation of [F-18]F-DPA PET for Detecting Microglial Activation in the Spinal Cord of a Rat Model of Neuropathic Pain (2022)
- Molecular Imaging and Biology
(A1 Refereed original research article in a scientific journal) - Evaluation of renal glucose uptake with [F-18]FDG-PET: methodological advancements and clinical outcomes (2022)
- Diabetologia
(Other publication) - Finnish-specific AKT2 gene variant leads to impaired insulin signalling in human myotubes (2022)
- Diabetologia
(Other publication) - Hepatic Positron Emission Tomography: Applications in Metabolism, Haemodynamics and Cancer (2022)
- Metabolites
(A2 Refereed review article in a scientific journal ) - Humans with metabolically active brown fat demonstrate higher capacity to catabolise branched chain amino acids (2022)
- Diabetologia
(Other publication) - Improved Aerobic Capacity and Adipokine Profile Together with Weight Loss Improve Glycemic Control without Changes in Skeletal Muscle GLUT-4 Gene Expression in Middle-Aged Subjects with Impaired Glucose Tolerance (2022)
- International Journal of Environmental Research and Public Health
(A1 Refereed original research article in a scientific journal) - Mahalaukun kavennus- ja ohitusleikkauksen kymmenen vuoden seuranta (2022)
- Duodecim
(Other publication) - Novel Effects of the Gastrointestinal Hormone Secretin on Cardiac Metabolism and Renal Function (2022)
- American Journal of Physiology : Endocrinology and Metabolism
(A1 Refereed original research article in a scientific journal) - Obesity associated blunted subcutaneous adipose tissue blood flow after meal is improved after bariatric surgery (2022)
- Journal of Clinical Endocrinology and Metabolism
(A1 Refereed original research article in a scientific journal) - Obesity risk is associated with altered cerebral glucose metabolism and decreased μ-opioid and CB1 receptor availability (2022)
- International Journal of Obesity
(A1 Refereed original research article in a scientific journal) - Obesity risk is associated with brain glucose uptake and insulin resistance (2022)
- European Journal of Endocrinology
(A1 Refereed original research article in a scientific journal) - Renal Sinus Fat Is Expanded in Patients with Obesity and/or Hypertension and Reduced by Bariatric Surgery Associated with Hypertension Remission (2022)
- Metabolites
(A1 Refereed original research article in a scientific journal) - SGLT2 inhibition reduces myocardial oxygen consumption (2022)
- Metabolism open
(A1 Refereed original research article in a scientific journal) - μ-opioid receptor availability is associated with sex drive in human males (2022)
- Cognitive, Affective, and Behavioral Neuroscience
(A1 Refereed original research article in a scientific journal) - Associations Between Brain Gray Matter Volumes and Adipose Tissue Metabolism in Healthy Adults (2021)
- Obesity
(A1 Refereed original research article in a scientific journal) - Brain Glucose Metabolism in Health, Obesity, and Cognitive Decline-Does Insulin Have Anything to Do with It? A Narrative Review (2021)
- Journal of Clinical Medicine
(A2 Refereed review article in a scientific journal ) - Cerebral μ-opioid and CB1 receptor systems have distinct roles in human feeding behavior (2021)
- Translational Psychiatry
(A1 Refereed original research article in a scientific journal) - Changes in electrocardiogram parameters during acute nonshivering cold exposure and associations with brown adipose tissue activity, plasma catecholamine levels, and brachial blood pressure in healthy adults (2021)
- Physiological Reports
(A1 Refereed original research article in a scientific journal) - Effect of Laparoscopic Sleeve Gastrectomy vs Roux-en-Y Gastric Bypass on Weight Loss and Quality of Life at 7 Years in Patients With Morbid Obesity: The SLEEVEPASS Randomized Clinical Trial (2021)
- JAMA Surgery
(A1 Refereed original research article in a scientific journal) - Effects of 6 weeks of treatment with dapagliflozin, a sodium- glucose co-transporter-2 inhibitor, on myocardial function and metabolism in patients with type 2 diabetes: A randomized, placebo-controlled, exploratory study (2021)
- Diabetes, Obesity and Metabolism
(A1 Refereed original research article in a scientific journal)
UTU Research Portal